Brice Rolston, MD
Allergy & Immunology · Covington, LANPI 1538137930
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,000 of the $54,271 with a category attached, or 68.2%. GSK accounts for 73.9% of it on its own, with 41 other manufacturers making up the rest. Reporting peaked in 2021 at $19,302 and has fallen 87.5% since, to $2,418 in 2025. Among allergy & immunology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 877 payments — averaging $61.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$40K
- AstraZeneca$3K
- CSL Behring$2K
- Regeneron Healthcare Solutions, Inc.$1K
- Grifols USA, LLC$1K
- Sanofi$866
- plus $5K from 36 others
What the payments were for
- Consulting fees$940%
- Speaking & faculty fees$37,00068%
- Food & beverage$16,93431%
- Education$2440%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TRELEGY ELLIPTA$32,300
- Gammaplex$125
- TEZSPIRE$100
How this compares
$54,271 in reported general payments places this provider in the 95th percentile of 62 allergy & immunology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 13 | $153,721 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 163 | $131,159 |
| Dupixent PenDupilumab | 19 | $70,816 |
| Dupixent SyringeDupilumab | 18 | $67,240 |
| Breo ElliptaFluticasone/Vilanterol | 106 | $57,009 |
| XolairOmalizumab | 15 | $51,986 |
| TezspireTezepelumab-Ekko | 11 | $45,308 |
| Advair HfaFluticasone Propion/Salmeterol | 30 | $12,675 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 13 | $10,649 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 28 | $7,938 |
| Epinephrine | 21 | $5,045 |
| Azelastine Hcl | 99 | $4,158 |
| Arnuity ElliptaFluticasone Furoate | 16 | $4,078 |
| Wixela InhubFluticasone Propion/Salmeterol | 31 | $3,678 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,527 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta | $40,112 | $192,246285 claims |
| CSL BehringHizentra | $2,450 | $153,72113 claims |
| AstraZenecaTezspire, Breztri Aerosphere | $2,947 | $55,95724 claims |
| Hikma Pharmaceuticals USAEpinephrine | $13 | $5,04521 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 62 allergy & immunology providers in Louisiana.
Other allergy & immunology in Covington
- David KaufmanShreveport$678K
- Reena MehtaNew Orleans$159K
- Kenneth ParisNew Orleans$150K
- Caroline CapertonShreveport$52K
- Sonia KambojMarrero$29K
- Erin PrattLafayette$17K
- Adrianne EdmundsonPrairieville$12K
- Cheryl WilliamsNew Orleans$12K
- Sarah QayumMetairie$11K
- David SchneiderMetairie$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.